Lyell Immunopharma Statistics

Total Valuation

LYEL has a market cap or net worth of $132.38 million. The enterprise value is -$140.65 million.

Market Cap	132.38M
Enterprise Value	-140.65M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

LYEL has 14.81 million shares outstanding. The number of shares has increased by 7.75% in one year.

Current Share Class	14.81M
Shares Outstanding	14.81M
Shares Change (YoY)	+7.75%
Shares Change (QoQ)	+5.41%
Owned by Insiders (%)	3.21%
Owned by Institutions (%)	45.75%
Float	9.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,036.68
Forward PS	n/a
PB Ratio	0.39
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.49, with a Debt / Equity ratio of 0.17.

Current Ratio	7.49
Quick Ratio	7.30
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -71.20% and return on invested capital (ROIC) is -25.91%.

Return on Equity (ROE)	-71.20%
Return on Assets (ROA)	-24.40%
Return on Invested Capital (ROIC)	-25.91%
Return on Capital Employed (ROCE)	-56.48%
Revenue Per Employee	$217
Profits Per Employee	-$1.12M
Employee Count	300
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.49% in the last 52 weeks. The beta is -0.27, so LYEL's price volatility has been lower than the market average.

Beta (5Y)	-0.27
52-Week Price Change	-66.49%
50-Day Moving Average	9.13
200-Day Moving Average	14.84
Relative Strength Index (RSI)	45.34
Average Volume (20 Days)	269,972

Short Selling Information

The latest short interest is 355,342, so 2.40% of the outstanding shares have been sold short.

Short Interest	355,342
Short Previous Month	10.63M
Short % of Shares Out	2.40%
Short % of Float	3.70%
Short Ratio (days to cover)	1.74

Income Statement

In the last 12 months, LYEL had revenue of $65,000 and -$334.52 million in losses. Loss per share was -$24.63.

Revenue	65,000
Gross Profit	65,000
Operating Income	-219.45M
Pretax Income	-210.26M
Net Income	-334.52M
EBITDA	-201.40M
EBIT	-219.45M
Loss Per Share	-$24.63

Full Income Statement

Balance Sheet

The company has $301.18 million in cash and $57.09 million in debt, giving a net cash position of $273.04 million or $18.44 per share.

Cash & Cash Equivalents	301.18M
Total Debt	57.09M
Net Cash	273.04M
Net Cash Per Share	$18.44
Equity (Book Value)	336.52M
Book Value Per Share	22.79
Working Capital	267.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$175.12 million and capital expenditures -$680,000, giving a free cash flow of -$175.80 million.

Operating Cash Flow	-175.12M
Capital Expenditures	-680,000
Free Cash Flow	-175.80M
FCF Per Share	-$11.87

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-337,613.85%
Pretax Margin	-514,649.23%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LYEL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.75%
Shareholder Yield	-7.75%
Earnings Yield	-252.69%
FCF Yield	-132.79%

Analyst Forecast

The average price target for LYEL is $15.00, which is 67.79% higher than the current price. The consensus rating is "Sell".

Price Target	$15.00
Price Target Difference	67.79%
Analyst Consensus	Sell
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 2, 2025. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jun 2, 2025
Split Type	Reverse
Split Ratio	0.05:1

Scores

LYEL has an Altman Z-Score of -3.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.18
Piotroski F-Score	1